Application date
2021-03-02
Registration date
2021-03-02
Published date
2021-05-13
First use date
—
Renewal date
—
Expiry date
2031-03-02
Kind of mark
Individual
Mark feature
Word
NICE Classes
5Pharmaceuticals
Current owners
Activity Summary
Oppositions
0
P 0 · D 0
Assignments
0
Security: 0
Renewals
0
Prosecution events
0
History Timeline
17 events- 2023-09-05RecordEXN - Subsequent Designation— Pub# 2023/36 Gaz
- 2022-10-26RecordGP18N - Grant of Protection under Rule 18bis(1)— Pub# 2022/43 Gaz · @ IS
- 2022-09-19RecordOPN - Notification of possible opposition after 18 months— Pub# 2022/38 Gaz · @ IS
- 2022-06-23RecordGP18N - Grant of Protection under Rule 18bis(1)— Proc# 16001926 · Pub# 2022/25 Gaz · @ MX
- 2022-05-11RecordGP18N - Grant of Protection under Rule 18bis(1)— Pub# 2022/19 Gaz · @ LI
- 2022-04-22RecordGP18N - Grant of Protection under Rule 18bis(1)— Proc# 15794853 · Pub# 2022/17 Gaz · @ CH
- 2022-04-12RecordGP18N - Grant of Protection under Rule 18bis(1)— Proc# 15762444 · Pub# 2022/15 Gaz · @ BR
- 2022-03-16RecordGP18N - Grant of Protection under Rule 18bis(1)— Proc# 15661794 · Pub# 2022/11 Gaz · @ NO
- 2022-03-13RecordGP18N - Grant of Protection under Rule 18bis(1)— Proc# 15652297 · Pub# 2022/11 Gaz · @ UA
- 2022-02-28RecordGP18N - Grant of Protection under Rule 18bis(1)— Pub# 2022/9 Gaz · @ TR
- 2021-12-06RecordISN - Intermediate status regarding protection— Proc# 15316636 · Pub# 2021/49 Gaz · @ TR
- 2021-11-24RecordISN - Intermediate status regarding protection— Proc# 15268155 · Pub# 2021/47 Gaz · @ NO
- 2021-11-16RecordGP18N - Grant of Protection under Rule 18bis(1)— Proc# 15242699 · Pub# 2021/46 Gaz · @ IN
- 2021-09-23RecordGP18N - Grant of Protection under Rule 18bis(1)— Proc# 15055922 · Pub# 2021/38 Gaz · @ GB
- 2021-09-09RecordGP18N - Grant of Protection under Rule 18bis(1)— Proc# 15017222 · Pub# 2021/36 Gaz · @ CN
- 2021-08-30RecordGP18N - Grant of Protection under Rule 18bis(1)— Proc# 14980376 · Pub# 2021/35 Gaz · @ RU
- 2021-03-02RecordENN - New International Registration— Pub# 2021/17 Gaz · @ FR